Short-Term Rationing of Combination Antiretroviral Therapy: Impact on Morbidity, Mortality, and Loss to Follow-Up in a Large HIV Treatment Program in Western Kenya

Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/2722

Full metadata record

DC Field	Value	Language
dc.contributor.author	Kimaiyo Sylvester	-
dc.contributor.author	Siika Abraham Mosigisi	-
dc.date.accessioned	2019-02-07T13:01:37Z	-
dc.date.available	2019-02-07T13:01:37Z	-
dc.date.issued	2014-03-14	-
dc.identifier.uri	http://ir.mu.ac.ke:8080/xmlui/handle/123456789/2722	-
dc.description.abstract	Since the beginning of the HIV pandemic, almost 60 million people have been infected with HIV and 25 million have died from HIV-associated illnesses [1]. Sub-Saharan Africa is the region most affected by the pandemic and is home to 68% of all people living with HIV worldwide [1]. Since 2002, the international drive to scale up antiretroviral treatment has gained tremendous momentum [2], and by the close of 2009, an estimated 5.2 million persons were receiving combination antiretroviral treatment (cART). While this represents important progress, this still is only about 35% of the people who are estimated in need of treatment according to current standards of care	en_US
dc.language.iso	en	en_US
dc.publisher	Hindawi Publishing Corporation AIDS Research and Treatment	en_US
dc.subject	Antiretroviral Therapy	en_US
dc.title	Short-Term Rationing of Combination Antiretroviral Therapy: Impact on Morbidity, Mortality, and Loss to Follow-Up in a Large HIV Treatment Program in Western Kenya	en_US
dc.type	Article	en_US
Appears in Collections:	School of Medicine

Files in This Item:

File	Description	Size	Format
Kimaiyo Slyvester 2012.pdf		1.32 MB	Adobe PDF	View/Open